Several market players, and numerous research organizations are accelerating their research on avian influenza vaccine, which is expected to be a key driver for the avian influenza vaccine market.For instance, in April 2025, The University of Cambridge–based DioSynVax and Singapore's ACM Biolabs have signed a strategic deal to jointly develop a next-generation universal avian flu vaccine. In addition to strategic partnerships, regulatory authorities are initiating vaccination programs to mitig...

The global ADC technology market, valued at USD 2.34 billion in 2025, is projected to reach USD 3.44 billion in 2026 and USD 9.51 billion by 2040, representing a 7.5% CAGR during the forecast period 2026 to 2040. According to our projections, North America is likely to capture majority of the ADC technology market share in the current year. However, the market in Asia-Pacific is likely to grow at a relatively faster pace till 2040. The growth is being propelled by the presence of robust ADC phar...

Several market players are increasing their initiatives to support the development of new parenting apps with immersive features. For instance, in April 2025, Mamas & Papas successfully launched a new app to support parents during pregnancy and early parenthood. Similar to the new app launch, several market players and renown personalities are making considerable investments in this field. For instance, in March 2025, R. Madhavan (Indian celebrity) has made an investment in Parent Geenee (US bas...

Market players, such as Cutera, Fotona, and InMode are leveraging strategic initiatives, followed by latest product approval, collaborations and partnerships. For instance, in May 2025, Apyx® Medical announced that its AYON Body Contouring System™ has received 510(k) clearance from the USFDA for fat reduction and body contouring. As more market players continue to explore new technologies, we believe that fat cavitation market will remain progressive in the future.

Intraocular lens manufacturers are also aiming to develop next-generation IOLs that offer clearer vision and require minimal post-operative downtime for patients to return to their daily routines. For instance, in June 2025, Johnson & Johnson (US) launched TECHNIS Odyssey next-generation intraocular lens in Europe, Canada, and the Middle East to correct presbyopia. These consistent innovations indicate that the intraocular lens market will remain competitive and progressive during the forecast p...

With an increasing emphasis on omics for personalized drug creation and disease identification, resulting in a significant increase in the use of artificial intelligence (AI) in omics studies. The increased support of AI in the field provides significant opportunities for industry players to leverage collaborations and partnerships to drive innovations. For instance, in June 2025, BioAro (Canada) launched a groundbreaking PanOmiQ™ platform at the 2025 BIO International Convention in Boston. Th...

The global automated liquid handling systems market is estimated to grow from USD 3.26 billion in 2025 to reach USD 3.50 billion in 2026 and USD 6.35 billion by 2035, representing a higher CAGR of 6.8% during the forecast period 2026 to 2035. It is a well-known fact that innovation in the life science industry is primarily driven by advanced technologies that possess the tendency to maximize assay throughput and frequency. Currently, more than 130 automated liquid handler developers claim to pro...

Some of the notable specimen collection cards market growth drivers includes rising initiatives of prenatal and newborn screening to identify the potential risk of genetic diseases. Notably, the direct blood spot collection cards serve as a gold standard for newborn testing protocols as it maintains sample integrity during storage and transportation. Early detection allows for timely intervention and treatment, which can significantly improve health outcomes, prevent severe developmental delays,...

Companies like Philips Healthcare (Netherland), Honeywell (US) and PointClickCare (Canada) are increasing their initiatives to develop smart hardware and software solutions for personalized care. For instance, in January 2025, iWOW (Singapore), introduced two groundbreaking age-tech products, namely the BOP Monitor and BOP Presence at CES 2025. These products are a part of a comprehensive suite of IoT solutions aims to detect accidental fall and monitor the moment of senior at home to keep them...

The RNA sequencing service market, valued at USD 3.3 billion in 2025, is projected to reach USD 3.6 billion in 2026 and USD 7.5 billion by 2035, with a 8.5% CAGR during the forecast period 2026 to 2035. RNA sequencing was first introduced by Fredrick Sanger in 1977, who used chain termination method, also known sanger sequencing method / first generation sequencing method. Over time, RNA sequencing service market has witnessed several technological advancements, and different methods of RNA seq...

These 3D cell culture models and organoids are used for studying drug safety and efficacy. In addition to clinical studies, the growing focus on stem cell therapy and regenerative medicine has further bolstered the demand for advanced 3D cell cultures and organoids.Considering the significances of advanced technology-based models, several industrial players are aiming to develop advanced organoid technologies and platforms for drug discovery and clinical studies. For instance, in July 2025, MD A...

The global healthcare technology management market, valued at USD 30.09 billion in 2024, is projected to reach USD 34.18 billion in 2025 and USD 98.48 billion by 2035, representing a CAGR of 11.2% during the forecast period. As per the report of HIPAA journal, in 2024, there are over 14 data breaches cases that compromised over 1 million healthcare records, affecting around 1,90,000,000 million individuals. Healthcare technology management refers to the multidisciplinary approach that encompasse...

Several research programs are underway to develop advanced epigenetic therapies for targeting cancer or solid tumors. For instance, in January 2025, a study published in John Hopkins Medicine highlighted that a team of researchers at Johns Hopkins Kimmel Cancer Center and Chinese Academy of Sciences identify new epigenetic approach to target colorectal cancer. During this study, researchers found a mouse protein that disrupts cancer-causing chemicals within genes associated with colorectal cance...

Several industrial players are focusing on the expansion of their products and services. In May 2025, Elis Bio (spun-out of the University of Chiacago) announced the launch of SuperMethyl™, a fast bisulfite conversion kit which provides 99.5% methyl conversion within ten minutes, in 2024 Chicago BioCapital Summit. Earlier, in August 2024, Genentech signed a licensing agreement worth up to USD 2 billion with Sangamo Therapeutics to develop genomic medicines for treating neurodegenerative diseas...

The global genotoxicity testing market, valued at USD 1.4 billion in 2025, is projected to reach USD 1.5 billion in 2026 and USD 2.7 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. Genotoxicity refers to the property of hazardous (physical, chemical and biological) agents to cause damage to genetic information present within a cell. At present, more than 80 industry and non-industry players offer a variety of assays, such as Ames assay, micronucleus assay, chromosomal...

the market for veterinary digital pathology is also driven by the rising adoption of companion animals, and willing of pet owners to spend on their companion animals health. Considering the rising opportunities, several market players have shown active interest in the field for digital pathology innovations. For instance, in June 2025, MUSE Microscopy (US) launched MUSE veterinary digital pathology, the first-of-its-kind tissue-to-direct digital imaging to provide same-day result for tissue biop...

With increasing demand across healthcare and pharmaceutical industries, several market players are actively exploring new possibilities for innovations in this field. Market players, such as MGI Tech (China), Illumina (US), and NVIDIA (US) are leveraging partnerships for developing AI based digital genome technologies. For instance, in June 2025, MGI Tech (China) signed a strategic collaboration with GenePowerRx (India) to revolutionize the predictive healthcare and precision medicine landscape...

The global genome editing market, valued at $4.25 billion in 2025, is projected to reach $5.29 billion in 2026 and $13.36 billion by 2035, representing a CAGR of 10.8% during the forecast period 2026 to 2035. more than 1,100 active clinical trials are evaluating gene therapies across various phases of clinical studies. According to the World Health Organization (WHO), 10 out of every 1,000 individuals are affected by genetic disorders, with over 70 million people worldwide living with such condi...

The global non-viral drug delivery systems market, valued at USD 8.6 billion in 2025, is projected to reach USD 11.3 billion in 2026 and USD 20.4 billion by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In September 2024, NanoSyrinx raised USD 13 million in a seed funding round, in order to advance its intracellular nanosyringe technology that is aimed to target biologics to the sites that are difficult to target within the cell. The market report presents an in-depth analysis...

The AI-driven personalized nutrition has been further bolstered by the rising adoption of medical wearable devices, and smartphones that help to collect vital information for disease monitoring and management. Moreover, AI integration with nutrigenomics can help in determining vast amount of data generated through genomics, and metabolomics. Notably, this field is at the forefront of innovation, catering the attention of industrial players.For instance, in February 2025, Fay (US), a digital nutr...